Plain-English translation of NCT06219941 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to treat advanced cancers of the stomach, pancreas, and bile ducts. The medication targets cancer cells that have a specific protein called Claudin 18.2 on their surface. The study will test whether this medication works better alone or when combined with standard chemotherapy.
These cancers are very difficult to treat and have limited options, especially once they become advanced. Researchers believe that targeting the Claudin 18.2 protein specifically on cancer cells could help attack tumors more effectively while sparing healthy tissue.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic regularly to receive the medication as an intravenous infusion (through a vein in your arm). Depending on which part of the study you join, you may receive the medication alone or combined with chemotherapy. Throughout the trial, you will have blood tests, imaging scans, and physical exams to monitor how well the treatment is working and check for side effects.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States